These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34087061)

  • 21. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
    Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
    Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma.
    de Jong EJM; Janssen QP; Simons TFA; Besselink MG; Bonsing BA; Bouwense SAW; Geurts SME; Homs MYV; de Meijer VE; Tjan-Heijnen VCG; van Laarhoven HWM; Valkenburg-van Iersel LBJ; Wilmink JW; van der Geest LG; Koerkamp BG; de Vos-Geelen J;
    Int J Cancer; 2022 May; 150(10):1654-1663. PubMed ID: 34935139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence.
    Liu QQ; Shi XD; Ye YF; Tang QB; Lin HM; Yu XH; Zhang R; Liu C
    Cancer Immunol Immunother; 2023 Jun; 72(6):1753-1761. PubMed ID: 36648557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma.
    Morino K; Seo S; Yoh T; Nishino H; Yamanaka K; Fukumitsu K; Ishii T; Taura K; Okajima H; Kaido T; Uemoto S
    Anticancer Res; 2019 Apr; 39(4):2155-2161. PubMed ID: 30952762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies.
    Edeline J; Hirano S; Bertaut A; Konishi M; Benabdelghani M; Uesaka K; Watelet J; Ohtsuka M; Hammel P; Kaneoka Y; Joly JP; Yamamoto M; Monard L; Ambo Y; Louvet C; Ando M; Malka D; Nagino M; Phelip JM; Ebata T
    Eur J Cancer; 2022 Mar; 164():80-87. PubMed ID: 35182925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis.
    Schweitzer N; Weber T; Kirstein MM; Fischer M; Kratzel AM; Reineke-Plaaß T; Lehner F; Manns MP; Vogel A
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1347-1355. PubMed ID: 28314929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of Surgery and Adjuvant Chemotherapy for Distal Cholangiocarcinoma].
    Takahashi K; Kawaida H; Hosomura N; Amemiya H; Kono H; Nakata Y; Shimizu H; Shiraishi K; Furuya S; Akaike H; Kawaguchi Y; Sudo M; Inoue S; Ichikawa D
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2497-2499. PubMed ID: 32156977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.
    Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S; Shannon J; Vettorazzi E; Wege H
    BMC Cancer; 2015 Jul; 15():564. PubMed ID: 26228433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin.
    Martin RCG; Simo KA; Hansen P; Rocha F; Philips P; McMasters KM; Tatum CM; Kelly LR; Driscoll M; Sharma VR; Crocenzi TS; Scoggins CR
    Ann Surg Oncol; 2022 Sep; 29(9):5462-5473. PubMed ID: 35657463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial.
    Malka D; Cervera P; Foulon S; Trarbach T; de la Fouchardière C; Boucher E; Fartoux L; Faivre S; Blanc JF; Viret F; Assenat E; Seufferlein T; Herrmann T; Grenier J; Hammel P; Dollinger M; André T; Hahn P; Heinemann V; Rousseau V; Ducreux M; Pignon JP; Wendum D; Rosmorduc O; Greten TF;
    Lancet Oncol; 2014 Jul; 15(8):819-28. PubMed ID: 24852116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study.
    Shin DW; Kim MJ; Lee JC; Kim J; Woo SM; Lee WJ; Lee KH; Hwang JH
    Am J Clin Oncol; 2020 Jun; 43(6):422-427. PubMed ID: 32118610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study.
    Li H; Guo Y; Sun X; Lu Y; Chang S; Wang X; Gao S; Gao C; Zhao T
    Front Oncol; 2023; 13():1276037. PubMed ID: 37909023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.
    Noji T; Tsuchikawa T; Okamura K; Tanaka K; Nakanishi Y; Asano T; Nakamura T; Shichinohe T; Hirano S
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):442-8. PubMed ID: 27207604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Sahai V; Catalano PJ; Zalupski MM; Lubner SJ; Menge MR; Nimeiri HS; Munshi HG; Benson AB; O'Dwyer PJ
    JAMA Oncol; 2018 Dec; 4(12):1707-1712. PubMed ID: 30178032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study.
    Takashima S; Imai K; Atari M; Matsuo T; Nakayama K; Sato Y; Motoyama S; Shibata H; Nomura K; Minamiya Y
    World J Surg Oncol; 2020 Oct; 18(1):263. PubMed ID: 33032626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
    Hester C; Nassour I; Adams-Huet B; Augustine M; Choti MA; Minter RM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Gastrointest Surg; 2018 Dec; 22(12):2080-2087. PubMed ID: 30030718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of unresectable hilar cholangiocarcinoma successfully treated by gemcitabine and S-1 combination chemotherapy].
    Tada S; Fujikawa T; Tanaka A; Abe T; Yoshimoto Y; Maekawa H; Shimoike N; Tanaka H; Kawashima T; Shiraishi K
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1279-82. PubMed ID: 22902459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.